Characterization of Rabbit Polyclonal Sera against Recombinant Shiga Toxin and its Subunits for Detection of Stx-Producing E. coli
,
Abstract
Shiga toxin (Stx) is the principal virulence factor of Shigatoxigenic Escherichia coli (STEC), a food-born pathogen associated disease with uncomplicated diarrhea or the hemolytic-uremic syndrome.
In this study, rabbit polyclonal anti recombinant A, B subunits of Shiga toxin and holotoxin antisera were raised and employed for immunological purpose. By immunoblotting, these antisera recognized respective subunit and the holotoxin antiserum recognized both subunits, equally. The raised antisera could also neutralize the cytotoxicity of the shiga toxin on vero cells. The neutralizing ability of the prepared sera was compared for different subunits.
The neutralization of toxicity was observed by incubation of raised sera with the rStx or Shiga toxin from wild type strains. The inhibition of cell toxicity was shown by anti-A, anit-B and anti-AB antisera, separately. It was shown that anti-A antibody, more significantly recognized Stx producing strains, comparing to anti-B antibody.
These sera from immunized rabbits were also used as specific antibodies in Enzyme-Linked Immunosorbant Assay (ELISA) for detection of Shiga toxin. It was demonstrated that the raised antibodies especially antibody against A subunit could be a useful tool for immunological diagnosis of STEC induced infection.
1.Jacewicz M, Clausen H, Nudelman E, Donohue-Rolfe A, Keusch GT. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med 1986; 163(6):1391-404.
2. Jackson M, Deresiewicz R, Calderwood S. Mutational analysis of the Shiga toxin and Shiga-like toxin II enzymatic subunits. J Bacteriol 1990; 172(6):3346-50.
3. Donohue-Rolfe A, Kelley MA, Bennish M, Keusch GT.Enzyme-linked immunosorbent assay for shigella toxin. J Clin Microbiol 1986; 24(1):65-8.
4. Boyd B, Richardson S, Gariepy J. Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin. Infect Immun 1991; 59(3):750-7.
5. Gunzer F, Karch H. Expression of A and B subunits of Shiga-like toxin II as fusions with glutathione S-transferase and their potential for use in seroepidemiology. J Clin Microbiol 1993; 31(10):2604-10.
6. Bielaszewska M, Clarke I, Karmali MA, Petric M.Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits. Infect Immun 1997; 65(7):2509-16.
7. Byun Y, Ohmura M, Fujihashi K, Yamamoto S, McGhee JR, Udaka S, et al. Nasal immunization with E. coli verotoxin 1 (VT1)-B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies. Vaccine 2001; 19(15-16):2061-70.
8. Leung PH, Peiris JS, Ng WW, Yam WC. Polyclonal antibodies to glutathione S-transferase--verotoxin subunit a fusion proteins neutralize verotoxins. Clin Diagn Lab Immunol 2002; 9(3):687-92.
9. Ludwig K, Karmali MA, Sarkim V, Bobrowski C, Petric M, Karch H, et al. Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome. J Clin Microbiol 2001; 39(6):2272-9.
10. Ludwig K, Sarkim V, Bitzan M, Karmali MA, Bobrowski C, Ruder H, et al. Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome. J Clin Microbiol 2002; 40(5):1773-82.
11. Oloomi M, Bouzari S, Arshadi M. N-terminus leader sequence of Shiga toxin (Stx) 1 is essential for production of active recombinant protein in E. coli. Protein Pept Lett 2006; 13(5):509-12.
12. Babich H, Borenfreund E. Cytotoxicity of T-2 toxin and its metabolites determined with the neutral red cell viability assay. Appl Environ Microbiol 1991; 57(7):2101-3.
13. Gentry MK, Dalrymple JM. Quantitative microtiter cytotoxicity assay for Shigella toxin. J Clin Microbiol 1980; 12(3):361-6.
14. Schmitt CK, McKee ML, O'Brien AD. Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157: H- strain E32511. Infect Immun 1991; 59(3):1065-73.
15. Oloomi M, Bouzari S, Ajdary S. Immune responses of mice immunized with active recombinant shiga toxin and its derivatives. Iran J Allergy Asthma Immunol 2008;7(2):53-60.
16. Mendes-Ledesma MR, Rocha LB, Bueris V, Krause G, Beutin L, Franzolin MR, et al. Production and characterization of rabbit polyclonal sera against Shiga toxins Stx1 and Stx2 for detection of Shiga toxin-producing Escherichia coli. Microbiol Immunol 2008; 52(10):484-91.
17. Zhu C, Yu J, Yang Z, Davis K, Rios H, Wang B, et al.Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B. Clin Vaccine Immunol 2008; 15(2):359-66.
18. Beutin L, Zimmermann S, Gleier K. Pseudomonasaeruginosa can cause false-positive identification of verotoxin (Shiga-like toxin) production by a commercial enzyme immune assay system for the detection of Shiga- like toxins (SLTs). Infection 1996; 24(3):267-8.
| Files | ||
| Issue | Vol 10, No 1 (2011) | |
| Section | Articles | |
| Keywords | ||
| A and B Subunits Polyclonal Antibodies Shiga Toxin | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
